AT329554B - Verfahren zur herstellung neuer imidazo (2,1-b)thiazolderivate und ihrer salze - Google Patents

Verfahren zur herstellung neuer imidazo (2,1-b)thiazolderivate und ihrer salze

Info

Publication number
AT329554B
AT329554B AT1005173A AT1005173A AT329554B AT 329554 B AT329554 B AT 329554B AT 1005173 A AT1005173 A AT 1005173A AT 1005173 A AT1005173 A AT 1005173A AT 329554 B AT329554 B AT 329554B
Authority
AT
Austria
Prior art keywords
salts
preparation
thiazole derivatives
new imidazo
imidazo
Prior art date
Application number
AT1005173A
Other languages
English (en)
Other versions
ATA1005173A (de
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7242580A external-priority patent/FR2207708A1/fr
Priority claimed from FR7335158A external-priority patent/FR2245348A1/fr
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of ATA1005173A publication Critical patent/ATA1005173A/de
Application granted granted Critical
Publication of AT329554B publication Critical patent/AT329554B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT1005173A 1972-11-30 1973-11-30 Verfahren zur herstellung neuer imidazo (2,1-b)thiazolderivate und ihrer salze AT329554B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7242580A FR2207708A1 (en) 1972-11-30 1972-11-30 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity
FR7335158A FR2245348A1 (en) 1973-10-02 1973-10-02 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity

Publications (2)

Publication Number Publication Date
ATA1005173A ATA1005173A (de) 1975-08-15
AT329554B true AT329554B (de) 1976-05-25

Family

ID=26217429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1005173A AT329554B (de) 1972-11-30 1973-11-30 Verfahren zur herstellung neuer imidazo (2,1-b)thiazolderivate und ihrer salze

Country Status (20)

Country Link
US (1) US4005212A (de)
JP (1) JPS5314077B2 (de)
AR (1) AR203186A1 (de)
AT (1) AT329554B (de)
BE (1) BE808008A (de)
CA (1) CA1002955A (de)
CH (1) CH579577A5 (de)
DD (1) DD107697A5 (de)
DE (1) DE2359864A1 (de)
DK (1) DK136823B (de)
ES (1) ES421011A1 (de)
GB (1) GB1404708A (de)
HU (1) HU167368B (de)
IE (1) IE38552B1 (de)
IL (1) IL43723A (de)
LU (1) LU68887A1 (de)
NL (1) NL7316016A (de)
OA (1) OA04567A (de)
SE (1) SE399894B (de)
SU (1) SU518133A3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179460A (en) * 1977-07-06 1979-12-18 Dso "Pharmachim" Derivatives of R,S-[X2-(2-hydroxyethylamino)-1-phenyl]-ethylamine, and process
US4370482A (en) 1978-02-15 1983-01-25 American Cyanamid Co. Synthesis of tetramisole, levamisole and their derivatives
US4620009A (en) * 1980-03-17 1986-10-28 Cyanamid Agricultural De Puerto Rico, Inc. Synthesis of intermediates for tetramisole, levamisole and their derivatives
ZA827736B (en) * 1981-11-25 1983-08-31 Pfizer Bicyclic imidazole and imidazolines as ectoparasiticides and anthelmintics
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU409983B2 (en) * 1965-07-19 1970-12-31 Imperial Chemical Industries Of Australia New Zealand Limited Process for the manufacture of thia zolidines and thiazolidines produced thereby

Also Published As

Publication number Publication date
DK136823B (da) 1977-11-28
SE399894B (sv) 1978-03-06
AR203186A1 (es) 1975-08-22
CA1002955A (fr) 1977-01-04
IL43723A (en) 1976-07-30
LU68887A1 (de) 1974-07-05
IL43723A0 (en) 1974-03-14
SU518133A3 (ru) 1976-06-15
DD107697A5 (de) 1974-08-12
DK136823C (de) 1978-05-08
CH579577A5 (de) 1976-09-15
ES421011A1 (es) 1976-06-16
IE38552B1 (en) 1978-04-12
IE38552L (en) 1974-05-30
HU167368B (de) 1975-09-27
US4005212A (en) 1977-01-25
ATA1005173A (de) 1975-08-15
GB1404708A (en) 1975-09-03
JPS4993390A (de) 1974-09-05
AU6300973A (en) 1975-05-29
NL7316016A (de) 1974-06-04
DE2359864A1 (de) 1974-06-06
JPS5314077B2 (de) 1978-05-15
OA04567A (fr) 1980-05-31
BE808008A (fr) 1974-05-29

Similar Documents

Publication Publication Date Title
AT336006B (de) Verfahren zur herstellung neuer imidazolinderivate und ihrer salze
AT323728B (de) Verfahren zur herstellung neuer heterccyclischer benzamidverbindungen und ihrer salze
AT313288B (de) Verfahren zur Herstellung neuer, basisch substituierter Benzylphthalazon-Derivate und ihrer Salze
AT326117B (de) Verfahren zur herstellung neuer indolderivate und ihrer salze
AT321293B (de) Verfahren zur Herstellung neuer Benzimidazolderivate und ihrer Salze
AT329554B (de) Verfahren zur herstellung neuer imidazo (2,1-b)thiazolderivate und ihrer salze
AT326667B (de) Verfahren zur herstellung neuer dibenzo-oxazepin-, -thiazepin- oder -diazepin-derivate und ihrer salze
AT331239B (de) Verfahren zur herstellung neuer imidazolinderivate und ihrer salze
AT321308B (de) Verfahren zur Herstellung neuer Pyrimidinonderivate und ihrer Salze
AT334358B (de) Verfahren zur herstellung neuer benzimidazol-derivate und ihrer salze
ATA548873A (de) Verfahren zur herstellung neuer oxindolderivate und ihrer salze
AT328435B (de) Verfahren zur herstellung neuer imidazolderivate und ihrer salze
AT316547B (de) Verfahren zur Herstellung neuer mesoionischer 1,3,4-Thiadiazolimin-(5)-Derivate und ihrer Salze
AT302296B (de) Verfahren zur Herstellung neuer 2-Amino-5-nitrothiazolderivate und ihrer Salze
AT323733B (de) Verfahren zur herstellung neuer 1,2,3,4-tetrahydrocarbazolderivate und ihrer salze
AT311956B (de) Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze
AT320639B (de) Verfahren zur Herstellung neuer 4- oder 5-Nitroimidazole und ihrer Salze
AT337179B (de) Verfahren zur herstellung neuer 1,3-benzodioxol-derivate und ihrer salze
AT320645B (de) Verfahren zur Herstellung neuer 2-Carboxy-4-oxo-4H,10H-(2)-benzopyrano-[4,3-g]-(1)-benzopyrane und ihrer Salze
AT330772B (de) Verfahren zur herstellung neuer 1,4-benzodioxan-derivate und ihrer salze
AT303029B (de) Verfahren zur Herstellung neuer 3,5-Dioxopyrazolidinderivate und ihrer Salze
AT334894B (de) Verfahren zur herstellung neuer thiazolin- bzw. thiazolderivate und ihrer salze
AT324334B (de) Verfahren zur herstellung neuer beta-amino-acrylsäure-derivate und deren salze
AT318607B (de) Verfahren zur Herstellung neuer 5-Nitroimidazolderivate und ihrer Salze
ATA315375A (de) Verfahren zur herstellung neuer 1,4-benzodioxan-derivate und ihrer salze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee